CG

Cegedim SAPAR Cegedim Stock Report

Last reporting period 30 Jun, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.19

Micro

Exchange

XPAR - Euronext Paris

CGM.PA Stock Analysis

CG

Avoid

Based on Eyestock quantitative analysis, CGM.PA`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

21/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-61.3 %

Overvalued

Market cap $B

0.19

Dividend yield

2.15 %

Shares outstanding

13.66 B

Cegedim SA operates as a technology and services company, which engages in the digital data flow management for healthcare ecosystems and B2B. The company is headquartered in Boulogne-Billancourt, Ile-De-France. Cegedim is also a manufacturer of medical and para-medical management software, and designs management applications dedicated to the health insurance sector. The Company’s expertise falls into three sectors: Life Sciences which comprises solutions specifically designed for pharmaceutical companies; Healthcare professionals designed for doctors, pharmacists and paramedics, and Healthcare Insurance, which is designed for health insurance providers and for companies of any sectors. The firm operates through Webstar Health and a number of subsidiaries. Cegedim SA is present in approximately 80 countries around the world.

View Section: Eyestock Rating